Pulmocide raises $30m for inhaled anti-infectivesMarch 20, 2017A UK biotech company has raised $30 million to fund development of its treatments for respiratory infections. Privately-held Share X Pulmocide raises $30m for inhaled anti-infectives https://pharmaphorum.com/news/pulmocide-raises-30m-inhaled-anti-infectives/
